Becton Dickinson and Co
NYSE:BDX
Becton Dickinson and Co
NYSE:BDX
Price:
236 USD
-0.29%
Market Closed
Updated:
May 17, 2024
Becton Dickinson and Co
Income from Continuing Operations
|
Becton Dickinson and Co
Income from Continuing Operations Peer Comparison
Comparables:
BSX
EW
SYK
ABT
ISRG
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Income from Continuing Operations
$1.3B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
3%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Income from Continuing Operations
$1.8B
|
CAGR 3-Years
92%
|
CAGR 5-Years
0%
|
CAGR 10-Years
17%
|
|
|
Edwards Lifesciences Corp
NYSE:EW
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
18%
|
CAGR 5-Years
12%
|
CAGR 10-Years
17%
|
|
|
Stryker Corp
NYSE:SYK
|
Income from Continuing Operations
$3.4B
|
CAGR 3-Years
34%
|
CAGR 5-Years
11%
|
CAGR 10-Years
16%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Income from Continuing Operations
$5.6B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
13%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Income from Continuing Operations
$2B
|
CAGR 3-Years
19%
|
CAGR 5-Years
12%
|
CAGR 10-Years
14%
|
See Also
What is Becton Dickinson and Co's Income from Continuing Operations?
Income from Continuing Operations
1.3B
USD
1.3B
USD
Based on the financial report for Dec 31, 2023, Becton Dickinson and Co's Income from Continuing Operations amounts to 1.3B USD.
What is Becton Dickinson and Co's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
3%
3%
Over the last year, the Income from Continuing Operations growth was -17%. The average annual Income from Continuing Operations growth rates for Becton Dickinson and Co have been 7% over the past three years , -2% over the past five years , and 3% over the past ten years .
You don't have any saved screeners yet
